Activity and DNA binding of new organoamidoplatinum (II) complexes Teresa TalaricoDon R. PhillipsLorraine K. Webster OriginalPaper Pages: 1 - 15
Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin Thomas H. CorbettChiab PanchaporJames Rake OriginalPaper Pages: 17 - 27
Pharmacokinetics and metabolism of the staurosporine analogue CGP 41 251 in mice R. van GijnO. van TellingenJ.H. Beijnen OriginalPaper Pages: 29 - 41
A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drug Ian R. JudsonPhilip J. BealeBruno Reigner OriginalPaper Pages: 49 - 56
Leucovorin, 5-fluorouracil, and gemcitabine: A phase I study Elizabeth PoplinJohn RobertsEric Rubin OriginalPaper Pages: 57 - 61
Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812) Kendra D. TutschRhoda Z. ArzoomanianGeorge Wilding OriginalPaper Pages: 63 - 72
A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancer Danny RischinLorraine K. WebsterJames F. Bishop OriginalPaper Pages: 73 - 80
Phase I study of liposomal daunorubicin in patients with acute leukemia Jorge CortesSusan O'BrienHagop Kantarjian OriginalPaper Pages: 81 - 87
Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study Norbert VeyHagop KantarjianElihu Estey OriginalPaper Pages: 89 - 95
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma Sridhar ManiDavid SciortinoSteven Benner OriginalPaper Pages: 97 - 101
